A study on the abnormal expressions of proteins and miRNA from colonic mucosa in the patients with irritable bowel syndrome

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-CNRC-09000502

Enrollment

Unknown

Registered

2009-07-21

Start date

2006-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IBS

Interventions

Group IBS-D:biopsy

Group IBS-C:biopsy

control group:biopsy

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: the IBS-C or IBS-D patients without post-infection fuifilling on the Rome III criteria

Exclusion criteria

Exclusion criteria: 1. the patients with a history of enteric parenchymal disease or surgery; 2. Suffering from psychosis,neuronosis or other systemic parenchymal disease; 3. Pregnancy or lactant women; 4. IBS patients with a history of alimentary infection.

Design outcomes

Primary

Measure	Time frame
screen of abnormal expression proteins;Isobutyryl-CoA dehydrogenase;Aldehyde dehydrogenase;Cytosolic thiolase;aldolase A;WD repeat-containing protein 1;a-enolase;screen of miRNA;T-complex protein 1alpha;Thioredoxi;	—

Countries

China

Contacts

Public ContactYunsheng Yang

sunny888@medmail.com.cn+86 010 66939747

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026